These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 1574541
1. Drug-responsive symptoms during early neuroleptic treatment. Mazure CM, Nelson JC, Jatlow PI, Bowers MB. Psychiatry Res; 1992 Feb; 41(2):147-54. PubMed ID: 1574541 [Abstract] [Full Text] [Related]
2. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis. Mazure CM, Nelson JC, Jatlow PI, Bowers MB. Biol Psychiatry; 1991 Sep 01; 30(5):475-82. PubMed ID: 1932395 [Abstract] [Full Text] [Related]
3. Lithium in combination with perphenazine: effect on plasma monoamine metabolites. Bowers MB, Mazure CM, Nelson JC, Jatlow PI. Biol Psychiatry; 1992 Dec 15; 32(12):1102-7. PubMed ID: 1477190 [Abstract] [Full Text] [Related]
4. The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects. Mazure CM, Nelson JC, Jatlow PI, Kincare P, Bowers MB. J Clin Psychiatry; 1990 Aug 15; 51(8):330-4. PubMed ID: 2199431 [Abstract] [Full Text] [Related]
5. Psychotogenic drug use and neuroleptic response. Bowers MB, Mazure CM, Nelson JC, Jatlow PI. Schizophr Bull; 1990 Aug 15; 16(1):81-5. PubMed ID: 1970670 [Abstract] [Full Text] [Related]
8. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. Maes M, De Meester I, Scharpe S, Desnyder R, Ranjan R, Meltzer HY. Acta Psychiatr Scand; 1996 Jan 15; 93(1):1-8. PubMed ID: 8919323 [Abstract] [Full Text] [Related]
9. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release. Kulkarni J, Keks NA, Stuart G, Mackie B, Minas IH, Singh BS, Copolov DL. Acta Psychiatr Scand; 1990 Oct 15; 82(4):271-4. PubMed ID: 2260479 [Abstract] [Full Text] [Related]
10. [Pharmacological treatment of delusional depression]. Amore M, Giordani L, Giorgetti G, Zazzeri N. Minerva Psichiatr; 1996 Mar 15; 37(1):29-33. PubMed ID: 8804200 [Abstract] [Full Text] [Related]
11. Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial. Kramer MS, Vogel WH, DiJohnson C, Dewey DA, Sheves P, Cavicchia S, Little P, Schmidt R, Kimes I. Arch Gen Psychiatry; 1989 Oct 15; 46(10):922-8. PubMed ID: 2679483 [Abstract] [Full Text] [Related]
12. Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations. Baumann P, Eap CB, Zullino DF. J Nerv Ment Dis; 2001 Nov 15; 189(11):798-9. PubMed ID: 11758666 [No Abstract] [Full Text] [Related]
13. TSH-response patterns to TRH stimulation may indicate therapeutic mechanisms of antidepressant and neuroleptic drugs. Langer G, Resch F, Aschauer H, Keshavan MS, Koinig G, Schönbeck G, Dittrich R. Neuropsychobiology; 1984 Nov 15; 11(4):213-8. PubMed ID: 6436728 [Abstract] [Full Text] [Related]
14. Postpsychotic depression and negative symptoms: an investigation of syndromal overlap. Siris SG, Adan F, Cohen M, Mandeli J, Aronson A, Casey E. Am J Psychiatry; 1988 Dec 15; 145(12):1532-7. PubMed ID: 3057924 [Abstract] [Full Text] [Related]
17. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. Rothschild AJ, Samson JA, Bessette MP, Carter-Campbell JT. J Clin Psychiatry; 1993 Sep 15; 54(9):338-42. PubMed ID: 8104930 [Abstract] [Full Text] [Related]
19. Coadministration of fluvoxamine increases serum concentrations of haloperidol. Daniel DG, Randolph C, Jaskiw G, Handel S, Williams T, Abi-Dargham A, Shoaf S, Egan M, Elkashef A, Liboff S. J Clin Psychopharmacol; 1994 Oct 15; 14(5):340-3. PubMed ID: 7806690 [Abstract] [Full Text] [Related]